In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market. Dr. Davidson offers a behind-the-scenes look at how pharmaceutical compani...
All content for Industry Innovations is the property of National Lipid Association and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market. Dr. Davidson offers a behind-the-scenes look at how pharmaceutical compani...
Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO
Industry Innovations
42 minutes
1 year ago
Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO
In this episode of Industry Innovations, host Dr. Peter Jones is joined by Dr. Guy Mintz to explore an exciting advancement in cardiovascular care: LODOCO, a low-dose colchicine developed by Agepha Pharma. Backed by robust clinical trial data, LODOCO is an FDA-approved therapy targeting inflammation as a novel approach to reducing the risk of heart attacks. Learn how inflammation contributes to cardiovascular events and why this groundbreaking therapy is redefining prevention strategie...
Industry Innovations
In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market. Dr. Davidson offers a behind-the-scenes look at how pharmaceutical compani...
